# Alzheimer’s Reversal: New Study Offers Hope for Recovery
- For more than a century, Alzheimer’s disease has been widely viewed as permanent and untreatable onc it begins. As an inevitable result, most research has focused on preventing the disease or slowing its progression rather than attempting to reverse it.
- By studying multiple mouse models of alzheimer’s alongside human Alzheimer’s brain tissue,researchers identified a critical biological problem at the center of the disease. They found that the brain’s inability to maintain healthy levels of a vital cellular energy molecule called NAD+ plays a major role in driving Alzheimer’s.
- In animal models, maintaining normal brain NAD+ levels prevented Alzheimer’s from developing. Even more striking, restoring NAD+ balance after the disease was already advanced allowed the brain to repair damage and fully restore cognitive function.
- These results suggest that treatments aimed at restoring the brain’s energy balance could potentially move Alzheimer’s therapy beyond slowing decline and toward meaningful recovery.
- The findings also open the door to further research, including the exploration of complementary strategies and carefully designed clinical trials to determine whether these results can translate to patients.
A Longstanding View of Alzheimer’s Is Being Questioned
for more than 100 years, Alzheimer’s disease (AD) has been widely viewed as a condition that cannot be undone. As of this belief, most scientific efforts have focused on preventing the disease or slowing its progression, rather than attempting to restore lost brain function. Even after decades of research and billions of dollars in investment,no drug trial for Alzheimer’s has ever been designed wiht the goal of reversing the disease and recovering cognitive abilities.
That long-held assumption is now being challenged by researchers from University Hospitals, Case Western Reserve University, and the Louis Stokes Cleveland VA Medical Center.Their work set out to answer a bold question: can brains already damaged by advanced Alzheimer’s recover?
New Study Targets Brain Energy Failure
The research was led by Kalyani Chaubey, PhD, of the Pieper Laboratory and published on December 22 in Cell Reports Medicine. By examining both human Alzheimer’s brain tissue and multiple preclinical mouse models, the team identified a key biological failure at the center of the disease. They found that the brain’s inability to maintain normal levels of a critical cellular energy molecule called NAD+ plays a major role in driving Alzheimer’s. Importantly, maintaining proper NAD+ balance was shown to not only prevent the disease but also reverse it in experimental models.
NAD+ levels naturally decline throughout the body, including the brain, as people age. When NAD+ drops too low, cells lose the ability to carry out essential processes needed for normal function and survival. The researchers discovered that this decline is far more severe in the brains of people with Alzheimer’s.The same pattern was seen in mouse models of the disease.
How Alzheimer’s Was Modeled in the Lab
Although Alzheimer’s occurs only in humans, scientists study it using specially engineered mice that carry genetic mutations known to cause the disease in people. In this study, researchers used two such models. One group of mice carried multiple human mutations affecting amyloid processing, while the other carried a human mutation in the tau protein.
Amyloid and tau abnormalities are among the earliest and most meaningful features of Alzheimer’s. In both mouse models, these mutations led to widespread brain damage that closely mirrors the human disease. This included breakdown of the blood-brain barrier, damage to nerve fibers, chronic inflammation, reduced formation of new neurons in the hippocampus, weakened communication between brain regions, and significant memory loss.
Worth a look